PROTEOGENIX
LIVE

Serial Number

79406602

Owner

FUNFROCK Philippe

Attorney

Richard A. Castellano

Filing Date

Aug 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PROTEOGENIX Trademark

Serial Number: 79406602

PROTEOGENIX is a trademark filed by FUNFROCK Philippe on August 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

FUNFROCK Philippe

30 rue Camille Claus

Entity Type: 01

Trademark Details

Filing Date

August 26, 2024

Registration Date

Not Registered

Goods & Services

Scientific and technological research in the fields of molecular biology, immunology, biotechnology, and diagnostics; biomedical research laboratory services; custom gene synthesis and peptide synthesis services; protein and antibody production and engineering; antibody humanization, maturation and optimization services; epitope and paratope mapping, antibody discovery services, Phage display, single B-cell screening, hybridoma development.

Biological and chemical products, chemical reagents, biological reagents, cell culture media, fermentation media, cell culture additives, recombinant proteins, monoclonal or polyclonal antibodies, non-medical detection and analysis kits, enzymes, buffers, lysis solutions, transfection agents, plasmids, synthetic or natural nucleic acids (DNA, RNA) for scientific, industrial or research use, synthetic peptides, products for peptide or genetic synthesis, expression vectors, cell lines, screening and selection products, reagents for PCR, qPCR, RT-PCR, NGS, proteomics, transcriptomics or genomics, analytical standards, isotopic or fluorescent labeling compounds, substances for the development of in vitro diagnostic tests, scientific consumables containing biological reagents, reagents for bioproduction, reagents for protein engineering, reagents for post-translational modifications, reagents for the development of vaccines or immunotherapies, raw materials for the manufacturing of biological drugs or diagnostic products for research use, and all chemical and biological products intended for biomedical research in life sciences, biotechnology, human and animal health, pharmacology, and diagnostics.

Laboratory apparatus and instruments for use in biotechnology, molecular biology, immunology and diagnostic research; scientific diagnostic instruments for detecting DNA, proteins, antibodies, and other biomolecules, for research use only; in vitro laboratory equipment for scientific purposes, namely devices for analyzing biological samples in research laboratories.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 26, 2026 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2026 TROA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 9, 2026 OPNR
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Mar 5, 2026 GAUN
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Mar 5, 2026 GAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Mar 5, 2026 NAUD
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 14, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
May 2, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2024 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 10, 2024 SDRC